Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES projectAnne Drapkin Lyerly, Leslie E. Wolf, Susan E. Cohn et al.|Journal of the International AIDS Society|2021Cited by 56
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsLynne Mofenson, Nathan Ford, Anton Pozniak et al.|Journal of the International AIDS Society|2019Cited by 43